Clinical Trials Logo

Pulp Disease, Dental clinical trials

View clinical trials related to Pulp Disease, Dental.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06380296 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Outcomes of NeoMTA and NeoPUTTY Pulpotomies in Primary Molars

Start date: April 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the outcomes of different medications used for pulpotomies (baby root canal) in children. The main question it aims to answer is: • what are the long-term clinical and radiographic success of pulpotomies in baby teeth using two different medications (NeoMTA and NeoPUTTY) over a 24-month follow-up period? Healthy children aged between 3 and 10 years undergoing dental treatment under general anesthesia who have deep caries lesions approximating or reaching the nerve will be invited to participate in this study. Pulpotomies (baby root canal) will be performed by trained dentists following a protocol. Children will receive pulpotomies either with NeoMTA or NeoPUTTY, two medications indicated for the procedure. Participants will be asked to come for an appointment at 1, 6, 12 and 24 months after the procedure. Researcher will compare the clinical and radiographic performance of pulpotomies (baby root canal) done with both medications.

NCT ID: NCT06170775 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

Start date: December 20, 2023
Phase: N/A
Study type: Interventional

Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy

NCT ID: NCT06170762 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Immature Permanent Teeth

Start date: December 20, 2023
Phase: N/A
Study type: Interventional

Sodiumhexametaphosphate will be used as capping material for dental pulp of immature permanent teeth

NCT ID: NCT05981352 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Evaluation of Different Materials in Pulpotomy of Primary Molars

Start date: October 2023
Phase: N/A
Study type: Interventional

The aim of the current study is to evaluate and compare clinical and radiographic success and antibacterial effect of Hyaluronic Acid and Amniotic membrane pulpotomy in primary molars in comparison with MTA pulpotomy (Randomized Clinical Trial and In Vitro Study).

NCT ID: NCT05839548 Not yet recruiting - Clinical trials for Dental Caries in Children

Articaine Efficacy and Safety for 3 Years Old Children

Start date: June 1, 2023
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to determine the local anesthetic efficacy and safety of 4% Articaine compared 2% Mepivicaine in 3 years old children, by using infiltration technique for primary teeth that required restorative, pulp therapy, or dental extraction procedure, as assessed by measuring the pain experience during injection and treatment procedures, child's behavior during the procedure, and postoperative complications.

NCT ID: NCT04650113 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA

Start date: January 20, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

that's comparison between partial and complete pulpotomy techniques in primary teeth

NCT ID: NCT03368391 Not yet recruiting - Clinical trials for Pulp Disease, Dental

: Pulpal Blood Flow With the Use of Intra-nasal Anesthetic

Start date: January 3, 2018
Phase: Phase 4
Study type: Interventional

Anesthetics with vasoconstrictors decrease pulpal blood flow but the impact of intranasal local anesthetics on blood flow is unknown. This blinded, randomized crossover clinical trial will compare the effects of different local anesthetics on anterior teeth in healthy volunteers. On separate study visits patients will receive either traditional injections or intranasal administration of the following solutions: 2% lidocaine with 1:100,000 epi, 3% mepivacaine, tetracaine HCl and oxymetazoline HCl, or saline. The following variables will be assessed: pulpal blood flow, pulpal sensibility, pain on administration, and adverse outcomes.